Search
for
Sort by
Research 391–420 of 1000+
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Lipid nanocarriers as innovative strategies for hair regrowth
- ORAL MINOXIDIL EFFICACY AND SAFETY IN MALE ANDROGENETIC ALOPECIA - A LITERATURE REVIEW
- Contact sensitization to hair care allergens in scalp seborrheic dermatitis: associations with disease severity and microbiota profiles
- Circular approach for the sustainable valorization of IMTA Codium sp. for multitarget skin care applications
- Premature Hair Graying: Underlying Contributors and Management Approaches - An Updated Literature Review
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Engineering immune-competent hair follicle microphysiological systems: from organoid assembly to dynamic immune modelling
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Upadacitinib is effective in treating psoriasis combined with lichen planus: a case report
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Awareness, knowledge, and perceptions of alopecia among UK postgraduate students: a cross-sectional study
- Hair Aging Revisited: An Expert Delphi Consensus on Pathogenesis, Clinical Features, and Future Therapies
- Progressive Zinc and Iron Deficiency Following Bariatric Surgery in Iraqi Patients: A 12-Month Pilot Study
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Novel drugs of United States Food and Drug Administration approved in 2024
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial
- Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia
- Beyond skin deep: Self-compassion mediates the link between body shame and psychopathology in people with alopecia and psoriasis
- ALOPECIA ANDROGENÉTICA: DIAGNÓSTICO, TERAPIAS CLÍNICAS E PROCEDIMENTOS ESTÉTICOS
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- Application and progress of induced pluripotent stem in chronic wound healing: a narrative review
- Geriatric Dermatologic Therapy
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies